Mutation of CD20 gene causes resistance to therapy with rituximab

被引：0
|
作者：
Terui, Y
Sakurai, T
Mishima, Y
Mishima, Y
Yokoyama, M
Hatake, K
机构：
[1] Japanese Fdn Canc Res, Tokyo, Japan
[2] Morinaga Milk Co, Nutr Sci Lab, Kanagawa, Japan
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
140
引用
收藏
页码：78 / 79
页数：2
相关论文
共 50 条
  • [1] Regarding the loss of CD20 after rituximab therapy
    Lee, R
    Braylan, RC
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 118 (03) : 927 - 927
  • [2] Loss of CD20 expression in relapsed lymphomas after rituximab therapy
    Haidar, JH
    Shamseddine, A
    Salem, Z
    Mrad, YA
    Nasr, MR
    Zaatari, G
    Bazarbachi, A
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2003, 70 (05) : 330 - 332
  • [3] Anti CD20 (Rituximab) therapy in refractory pediatric rheumatic diseases
    Reis, J.
    Aguiar, F.
    Brito, I
    ACTA REUMATOLOGICA PORTUGUESA, 2016, 41 (01): : 45 - 55
  • [4] Rituximab in CD20 positive multiple myeloma
    J M Bergua
    C Cabrera
    E G Arteta
    J Prieto
    Leukemia, 2008, 22 : 1082 - 1083
  • [5] TRUNCATED CD20 AS SUICIDE GENE IN CARCIK THERAPY
    Cuofano, C.
    Correnti, F.
    Cattaneo, I.
    Zaninelli, S.
    Panna, S.
    Introna, M.
    Golay, J.
    HAEMATOLOGICA, 2022, 107 : 92 - 93
  • [6] Identification of CD20 mutation associated with modification of CD20 expression and poor prognosis after rituximab in non-Hodgkin's lymphoma
    Terui, Y.
    Mishima, Y.
    Yokoyama, M.
    Kodaira, M.
    Takeuchi, K.
    Hatake, K.
    ANNALS OF ONCOLOGY, 2008, 19 : 115 - 115
  • [7] Rituximab in CD20 positive multiple myeloma
    P Moreau
    L Voillat
    L Benboukher
    C Mathiot
    C Dumontet
    N Robillard
    O Hérault
    F Garnache
    R Garand
    N Varoqueaux
    H Avet-Loiseau
    J L Harousseau
    R Bataille
    Leukemia, 2007, 21 : 835 - 836
  • [8] Transient downmodulation of CD20 by rituximab.
    Jilani, I
    O'Brien, S
    Manshouri, T
    Thomas, DA
    Thomazy, VA
    Imam, M
    Naeem, S
    Verstovsek, S
    Kantarjian, H
    Giles, F
    Keating, M
    Albitar, M
    BLOOD, 2002, 100 (11) : 804A - 804A
  • [9] Rituximab in CD20 positive multiple myeloma
    Moreau, P.
    Voillat, L.
    Benboukher, L.
    Mathiot, C.
    Dumontet, C.
    Robillard, N.
    Herault, O.
    Garnache, F.
    Garand, R.
    Varoqueaux, N.
    Avet-Loiseau, H.
    Harousseau, J. L.
    Bataille, R.
    LEUKEMIA, 2007, 21 (04) : 835 - +
  • [10] Rituximab in CD20 positive multiple myeloma
    Bergua, J. M.
    Cabrera, C.
    Arteta, E. G.
    Prieto, J.
    LEUKEMIA, 2008, 22 (05) : 1082 - 1083
12345